Technology
Health
Pharmaceutical

argenx SE

$147.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.49 (-1.65%) Today
-$0.27 (-0.18%) As of 4:05 PM EDT after-hours

Why Robinhood?

You can buy or sell argenx SE and other stocks, options, ETFs, and crypto commission-free!

About ARGX

argenx SE American Depositary Shares, also called argenx SE, is a clinical-stage biotechnology company, which engages in the development of antibody-based therapies for the treatment of autoimmune diseases and cancer. Its products include ARGX-113 for the treatment of autoimmune disease myasthenia gravis and ARGX-110 for the treatment of hematological cancer acute myeloid leukemia. Read More The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren on April 25, 2008 and is headquartered in Breda, the Netherlands.

Employees
105
Headquarters
Breda, Noord-Brabant
Founded
2008
Market Cap
5.41B
Price-Earnings Ratio
Dividend Yield
Average Volume
108.48K
High Today
$150.41
Low Today
$146.71
Open Price
$150.31
Volume
94.42K
52 Week High
$150.92
52 Week Low
$63.81

Collections

Technology
Health
Pharmaceutical
Cancer Prevention
Medical
Biotechnology
2017 IPO
Europe (Non-UK)

ARGX Earnings

-$0.90
-$0.54
-$0.17
$0.19
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Aug 1, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.